web analytics
Stability Indicating Method | Solubility Property Determination | Pharmaceutical Development

What is a stability indicating method?

How does Velesco prepare a stability indicating method for our clients?

Velesco pharmaceutical development specialists will develop a stability indicating method by researching your compound to determine solubility properties and suitable detection wavelength for HPLC.

 

News and Events

 

Newly Acquired DEA Analytical Laboratory License.  We are licensed to use schedules 2, 2N, 3, 3N, 4, and 5.

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services.

 

 

New Velesco Pharma clinical manufacturing facility begins operations. Read the press release here.

Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.  Read the interview here.

 

Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group. Read the press release here.

  

CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing

  

1 new job postings! Careers 

  

Velesco's work published 

  Formulation Development & Manufacturing:

Using a Single Provider Reduces Costs & Risk

Read it here.

  

Follow Velesco: 

 LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter  FB FindUsOnFacebook 100

 

734-274-9877